Vestibular Rehabilitation With Intratympanic Drug Therapy in Meniere's Disease
NCT ID: NCT05355610
Last Updated: 2022-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
93 participants
INTERVENTIONAL
2021-04-01
2022-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
At the same time intratympanic dexamethasone will be used to rescue hearing
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Intratympanic Dexamethasone With Ligmocaine for Alleviation of Tinnitus
NCT04798391
Paroxysmal Positional Vertigo & Repositioning Maneuvers
NCT05309538
The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease
NCT05851508
Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease
NCT00802529
Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.
NCT06025097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At the same time intratympanic dexamethasone will be used to rescue hearing measured with speech reception threshold and speech discrimination threshold
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
At the same time intratympanic dexamethasone will be used to rescue hearing measured with speech reception threshold and speech discrimination threshold
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vestibular severity index improvement
Improvement in vestibular symptoms with intratympanic gentamicin
Gentamicin
Intratympanic gentamicin and dexamethasone administered in two doses one week apart
Dexamethasone
Intratympanic gentamicin and dexamethasone administered in two doses one week apart
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gentamicin
Intratympanic gentamicin and dexamethasone administered in two doses one week apart
Dexamethasone
Intratympanic gentamicin and dexamethasone administered in two doses one week apart
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
24 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Combined Military Hospital Quetta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Zeeshan Ayub
Associate Professor ENT
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zeeshan Ayub, FCPS
Role: PRINCIPAL_INVESTIGATOR
CMH Quetta
Zeeshan Ayub, FCPS
Role: STUDY_CHAIR
CMH Quetta
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CMH Quetta
Quetta, Balochistan, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zeeshan Ayub, FCPS
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
File No: CMH QTA-IRB/043
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.